Dna X (SONM) Cash from Financing Activities (2018 - 2025)
Dna X filings provide 8 years of Cash from Financing Activities readings, the most recent being $1.2 million for Q4 2025.
- On a quarterly basis, Cash from Financing Activities rose 46.25% to $1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $19.5 million, a 319.41% increase, with the full-year FY2025 number at $19.5 million, up 319.41% from a year prior.
- Cash from Financing Activities hit $1.2 million in Q4 2025 for Dna X, down from $7.2 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $18.6 million in Q4 2021 to a low of -$37000.0 in Q1 2023.
- Median Cash from Financing Activities over the past 5 years was $591000.0 (2023), compared with a mean of $3.3 million.
- Biggest five-year swings in Cash from Financing Activities: surged 676200.0% in 2022 and later plummeted 511.11% in 2023.
- Dna X's Cash from Financing Activities stood at $18.6 million in 2021, then plummeted by 100.19% to -$36000.0 in 2022, then fell by 2.78% to -$37000.0 in 2023, then soared by 2262.16% to $800000.0 in 2024, then surged by 46.25% to $1.2 million in 2025.
- The last three reported values for Cash from Financing Activities were $1.2 million (Q4 2025), $7.2 million (Q3 2025), and $4.8 million (Q2 2025) per Business Quant data.